Summit CME Info 2021

To receive your CME credit:

To receive credit, participants are required to complete the evaluation. Once the evaluation is completed, a certificate will be immediately available and also emailed. There is no fee to participate in the activity or for the generation of the certificate.

NOTE: You will only be able to claim credit 1 time. Be sure to watch all presentations before claiming credit. If you claim credit for 1 presentation and watch another at a later date, you will not be able to claim credit again.

To receive credit:
1. Go to www.ACHLcme.org
2. Click on “Get Certificate” in the top right corner 
3. Login or register
4. Enter the Certificate Code: 4554937
5. Complete the meeting evaluation and your certificate will be immediately available to you and emailed to you. 

Participants will receive an automated certificate. You may print or save this record for your files. It will also be sent to you via email to the address provided in your profile on www.ACHLcme.org. 

There is no fee for the generation of this certificate.
If you have any trouble with your evaluation and certificate, please contact Melissa Stradal at mstradal@achlcme.org.

Joint Providership Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and Lymphatic Education & Research Network (LE&RN).  ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Academy for Continued Healthcare Learning designates this enduring material for up to 9.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience
This activity is intended for physicians, nurses, and other allied health professionals who treat patients with lymphedema.

Learning Objectives
Upon completion of this activity, participants will be able to:
• Utilize the emerging investigative concepts as they relate to the biology of the lymphatic system in health and disease
• Utilize appropriate diagnostic interventions for patients with lymphatic disease throughout the lymphatic continuum
• Recommend state-of-the-art treatment options and interventions for patients with lymphatic disease, including those with lymphedema and lymphedema-related cellulitis, phlebolymphedema, lipedema, and lymphatic and complex vascular malformations• Recognize the impact of normal and abnormal lymphatic function within the broad realm of organ-specific morbidity and mortality

Faculty
Denise Adams; Jean-Paul Belgrado; Francine Blei; Håkan Brorson; Kathleen Caron; Michael Dellinger; Brandon Dixon; Sergio Gianesini; Emily Iker; Max Itkin; Xinguo Jiang; Vaughan Keeley; Babak Mehrara; Christine Moffatt; Peter Mortimer; Thomas O’Donnell; Guillermo Oliver; Pia Ostergaard; Tim Padera; Isabelle Quéré; Willam Repicci; Stanley G. Rockson; Dhruv Singhal; Andrzej Szuba; Susan Thomas; Miikka Vikkula; Pierre-Yves von der Weid.

Disclaimer
All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Faculty Disclosures
ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity. 

Staff and Reviewer Disclosures
ACHL staff members, LE&RN staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Sponsorship
This activity is sponsored by: